We have studied plasma renin activity, the plasma aldosterone level and urinary metabolites of glucocorticoid precursors before and during a dexamethasone suppression test in three non-salt-losers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency, who had never been treated with glucocorticoid.
A high aldosterone secretion rate (Bartter et at., 1968; Dahl et al., 1972; Kowarski et al., 1965) and elevated plasma renin activity (PRA) (Sassard et al., 1969; Simopoulos et al., 1971) were reported in nonsalt-losers with congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
The mechanism by which aldosterone secretion is increased in these patients is not yet fully understood.
One of the hypotheses proposed is that hyperaldosteronism in non-salt-losers is secondary to the natriuretic effects of excess glucocorticoid precursors, such as 17a-hydroxyprogesterone and progesterone (Bartter, 1977) . As a corollary of this hypothesis, PRA and aldosterone levels are expected to be normalized if the excessive secretion of glucocorticoid precursors is suppressed by glucocorticoid administration.
However, PRA were often found to be high above normal levels in the patients under glucocorticoid therapy (Kinoshita, 1976; Limal et al., 1977; Rosler et al., 1977) .
In the present study, we have measured PRA and the aldosterone level in non-saltlosers who had never been treated with glucocorticoid previonsly.
As a result, we have found a dissociation of PRA and aldosterone level in these patients during a dexamethasone suppression test.
Subjects and Methods
We studied three adult patients, with a non-salt- in all these patients was confirmed according to their clinical histories, physical findings, cytogenetic studies, and endocrine studies including urinary excretion of 17KS, pregnanetriol and pregnanetriolone. Case 1 was a 31-year-old genetic female, who had been reared as a male subject due to misassignment of sex at birth because of ambiguous external genitalia (Ishida et al., 1976) . Case 2 was a 28-year-old genetic female who also had been reared as a male because of ambiguous external gentitalia. Case 3 was a 26-year-old male both genetically and socially.
They were put on a constant sodium intake (Na 137-170 mEq/day).
After demonstrating adequate sodium balance, they were given 2mg of dexamethasone orally (0.5 mg q.i.d.) each day for 7 days. Blood and urine samples were collected for biochemical analysis.
Blood samples were drawn before breakfast after overnight recumbency on the 1st day, the 3rd day and the 7th day of dexamethasone administration as well as on the day before administration.
The urinary pregnanetriol and pregnanetriolone excretions were determined using gas liquid chromatography by a previously reported method (Kinoshita et al., 1966) . PRA was determined by bioassay in case 1 (normal range; 3-25 ng/ml) and by radioimmunoassay in cases 2 and 3 (normal range; 0.7-2.9 ng/m/hr).
The plasma aldosterone level was determined by a radioimmunoassay method. Then normal range for aldosterone in case 1 (5-20 ng/dl) was different from that in cases 2 and 3 (0.5-5 ng/dl), because they were determined at different laboratories*. Table 2 . In case 1, the plasma aldosterone level was found to be abnormally high, i.e. 48.0 ng/ dl, before dexamethasone administration. Unfortunately PRA before dexamethasone administration was not measured, but on the 1st day during dexamethasone administration the level was found to be elevated, i.e. 86.9 ng/ml.
It was noticed that PRA always remained elevated during 7 days of dexamethasone administration. One the other hand the plasma aldosterone level was lowered to the normal range on the 3rd day after the initiation of dexamethasone administration in parallel with the decrease in urinary 17KS excretion.
The PRA and aldosterone levels in cases 2 and 3 were also found to be abnormally high before dexamethasone administration. As observed in case 1, their plasma aldosterone levels were lowered along with a decrease in 
Discussion
Opinions differ concerning the mechanism by which aldosterone secretion is increased in non-salt-losers with 21-hydroxylase deficiency. One of the hypotheses proposed (Bartter, 1977) , is that 21-hydroxylation for progesterone, i.e., the aldosterone synthetic pathway, is intact in nonsalt-losers in contrast to salt-losers, although 21-hydroxylation for 17a-hydroxyprogesterone is affected in both forms of the disease. On this assumption, hyperaldosteronism in non-salt-losers is considered to be secondary and an attempt is made at physiological compensation for the sodium loss, which is induced by sodium releasing effects of excessively produced glucocorticoid precursors. It has been reported that progesterone, 17a-hydroxyprogesterone and 16a-hydroxyprogesterone, have natriuretic effects in humans, antagonistic to aldosterone at its site of action in the distal tubules of the kidney (Janoski, 1977) . As a corollary of this hypothesis, elevated PRA should be lowered in association with plasma aldosterone level when the secretion of these ACTH dependent aldosterone antagonists is suppressed by glucocorticoid administration.
However, elevated PRA was reported in non-saltlosers (Kinoshita, 1976; Limal et al., 1977; Rosler et al., 1977) under glucocorticoid therapy where secretion of ACTH dependent aldosterone antagonists were suppressed adequately, as judged by urinary 17KS or pregnanetriol excretion or other indexes.
In the present study, we demonstrated that the PRA and aldosterone level were abnormally elevated in non-salt-losers who had never been treated with glucocorticoid Endocrinol. Japon. December 1980 previously, and PRA in these patients remained still high above normal level after 7 days' dexamethasone administration when the hypersecretion of aldosterone was suppressed in parallel with the other glucocorticoid precursor steroids. A similar discordant suppression of the PRA and aldosterone level was reported in salt-losers, in whom previous mineralocorticoid treatment were discontinued for the examination (Keenan et al., 1979) .
The mechanism of this dissociated suppression of the PRA and aldosterone level in non-salt-losers cannot be defined from our present study. However, one possibility is that 21-hydroxylation for progesterone may also be affected in non-salt-losers, though not so severely as in salt-losers. On this assumption, the elevation of PRA is considered to be mandatory for sufficient secretion of aldosterone, even after the suppression of ACTH dependent aldosterone antagonists.
However, this assumption is contradictory to much reported evidence suggesting normal 21-hydroxylation for progesterone in non-salt-losers (Bartter et al., 1968; Dahl et al., 1972; Kowarski et al., 1965) . Another possible explanation is the presence of mineralocorticoid resistance in these patients which is unrelated to ACTH dependent mineralocorticoid antagonists. Two possibilties were suggested by Keenan et al., (1979) in salt-losing 21-hydroxylase deficiency patients, i.e., the existence of an intrinsic renal insensitivity to aldosterone and the involvement of a renin-dependent aldosterone antagonist.
It is also noteworthy that there has been increasing evidence indicating the involvement of prostaglandin and/or the kinin-kallikrein system in renin releasing mechanism (Levinsky, 1979) .
In conclusion, we have demonstrated dissociated suppression of PRA and aldosterone level during 7 days' dexamethasone administration in non-salt-losers with congenital adrenal hyperplasia due to 21-hy- 
